Compare INDO & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INDO | ZTEK |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | Indonesia | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Major Chemicals |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.3M | 78.2M |
| IPO Year | 2019 | N/A |
| Metric | INDO | ZTEK |
|---|---|---|
| Price | $3.70 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 76.9K |
| Earning Date | 09-30-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,293,625.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $2.10 | $0.62 |
| 52 Week High | $7.95 | $1.84 |
| Indicator | INDO | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 40.96 |
| Support Level | $3.25 | $0.63 |
| Resistance Level | $4.06 | $0.74 |
| Average True Range (ATR) | 0.47 | 0.07 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 20.10 | 12.74 |
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.